Synopsis
Newly Added Guidance Documents Topic Guidance Status Date Combination Products Essential Drug Delivery Performance Characteristics for Devices Intended to Deliver Drugs and Biological Products Draft 10/29/2026 Technical Specifications Submitting Clinical Trial Data to Evaluate the Ability to Operate a Motor Vehicle Final 10/20/2026 Labeling Regulatory Considerations for Prescription Drug Use-Related Software Final 10/20/2026 Biosimilars Postapproval Manufacturing Changes to B
Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.
Read the full story at FDA: drugs ↗
